Table 1 Baseline patient characteristics
Parameter | Cohort (n = 111) |
|---|---|
Median age | 68 (42–90) years |
Male | 77 (69.4%) |
ECOG PS | |
0 | 13 (11.7%) |
1 | 70 (63.1%) |
2 | 26 (23.4%) |
3 | 2 (1.8%) |
Stage | |
IIIA | 60 (54.1%) |
IIIB | 51 (45.9%) |
Histology | |
Adenocarcinoma | 52 (46.8%) |
Squamous Cell Carcinoma | 44 (39.6%) |
Large Cell | 3 (2.7%) |
Adenosquamous | 2 (1.8%) |
NOS | 10 (9.0%) |
Median RT dose | 66 (60–74) Gy |
60–66 Gy | 84 (75.7%) |
> 66–74 Gy | 27 (24.3%) |
Concurrent chemotherapy | 106 (95.5%) |
Median follow up, months | 38.7 (0.1–109.2) |